NCT05964114View on ClinicalTrials.gov

First Time Right of Vancomycin

NANot yet recruitingINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

June 30, 2026

Conditions

VancomycinPharmacokinetics

Interventions

DRUG

Vancomycin

Initial dosing based on (a combinations of) pharmacokinetic models tailored to the individual patient. Dose adjustment starting dose (within registered dosing range).